Cargando…
513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection
BACKGROUND: Antimicrobial stewardship programs (ASP) have been essential during the coronavirus disease 2019 (COVID-19) pandemic response. Use of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has proven difficult to operationalize, despite being ava...
Autores principales: | Abrantes-Figueiredo, Jessica, Nalewyko, Stephanie, Wiskirchen, Dora E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644493/ http://dx.doi.org/10.1093/ofid/ofab466.712 |
Ejemplares similares
-
1235. A Retrospective Review of Antimicrobial Stewardship Audit and Feedback: Assessing Acceptance of Stewardship Recommendations During the COVID-19 Pandemic
por: Colaluca, Melissa A, et al.
Publicado: (2023) -
203. Impact of an Infectious Diseases Fellow-Led Antimicrobial Stewardship Initiative in a Medical/Surgical ICU
por: Palmer, Ann, et al.
Publicado: (2018) -
Assessment of the effects of rapid diagnostic biofire blood culture identification panel in hospitalized patients
por: Cohen, Amy, et al.
Publicado: (2022) -
513. Viral kinetics of SARS-CoV-2 in patients with COVID-19
por: Kim, Da Young, et al.
Publicado: (2020) -
Antimicrobial stewardship programs in Emilia-Romagna, Italy
por: Pan, A, et al.
Publicado: (2011)